Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial

• Prif Awduron: Eduardo Cabrera-Rode (Awdur), Ileana Cubas-Dueñas (Awdur), Janet Rodríguez Acosta (Awdur), Jeddú Cruz Hernández (Awdur), Ana Ibis Conesa González (Awdur), Teresa M. González Calero (Awdur), Yuri Arnold Domínguez (Awdur), José Hernández Rodríguez (Awdur), Antonio D. Reyes Rodríguez (Awdur), Aimee Álvarez Álvarez (Awdur), Ragmila Echevarría Valdés (Awdur), Liudmila Jorge Espinosa (Awdur), Onelia Torres Belent (Awdur), Zoila Bell Benavides (Awdur), Elizabeth Senra Estévez (Awdur), Yanet Abreu Rodríguez (Awdur), Juana del Valle Rodríguez (Awdur), Silvia Marín Juliá (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: BMC, 2023-02-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Background Obex® may be helpful in reducing body weight and fat. The current study was carried out to evaluate the efficacy and safety of Obex® in the treatment of overweight and obese subjects. Methods A double-blind, randomised, controlled phase III clinical trial was conducted involving...